Northeast Community Bancorp Gains After Shareholders Approve 2026 Equity Plan

May 27, 2026
Northeast Community Bancorp Gains After Shareholders Approve 2026 Equity Plan

New York, May 27, 2026, 13:06 EDT

  • NECB was trading around 0.6% higher at $24.39 in midday trading. The regional bank ETF moved lower.
  • Shareholders backed the 2026 equity incentive plan and voted in four directors, according to a new SEC filing.
  • The move in the stock has investors watching construction lending growth, credit quality, and tighter bank margins.

NorthEast Community Bancorp shares moved up in midday trading Wednesday, outpacing regional banks. The company said shareholders signed off on a new equity incentive plan. The stock rose 14 cents to $24.39. Latest quote showed 8,764 shares had changed hands.

The timing stands out since the move landed during a normal Nasdaq session, just two days after U.S. markets shut for Memorial Day. It also came less than a day after the White Plains, New York lender filed a Form 8-K with results from its annual meeting. According to Nasdaq’s 2026 calendar, Memorial Day on May 25 was a market holiday, while the next full closure isn’t until Juneteenth on June 19.

NECB’s new filing didn’t surprise on earnings—it was about governance changes. Still, for a small bank with about $330 million in market cap and low volume, investors get another concern to weigh. The stock trades between its 52-week high at $25.61 and low at $19.27.

Shareholders signed off on the 2026 Equity Incentive Plan with 8,177,774 votes in favor, 553,081 against, and 139,307 abstentions, according to the SEC filing. There were 2,328,210 broker non-votes, meaning those shares weren’t voted since instructions were not given by the owners.

Shareholders voted in Lynette Bennett, Jose M. Collazo, John F. McKenzie, and Joel L. Morgenthau as directors, each set for three-year terms. S.R. Snodgrass, P.C. was also ratified as the company’s independent registered public accounting firm for the fiscal year ending Dec. 31, 2026.

NorthEast Community Bancorp’s most recent earnings are still what the market is watching. The company posted first-quarter net income of $10.0 million, or 74 cents a diluted share, compared to $10.6 million, or 78 cents a year ago.

CEO Kenneth A. Martinek said the bank kept a “laser focus” on construction lending across parts of the Bronx and Rockland, Orange and Sullivan counties, with “continued strong performance” in its loan portfolio. Construction loan commitments and loans-in-process jumped around 37.8% from a year ago, putting unfunded loan commitments above $819 million at March 31. GlobeNewswire

Credit quality held up in the quarter. The company reported zero non-performing loans or assets at both March 31 and Dec. 31. Allowance for credit losses stood at $4.6 million, which is 0.25% of loans.

Still, there’s the risk that more lending won’t make up for what’s being lost on margins. Net interest margin came down to 4.99% from 5.11% a year ago, as yields on assets dropped quicker than the cost of funds. Loans were down 1.7% from the end of last year. If construction demand slows further or deposit costs don’t move lower, shares may run out of steam.

Regional-bank stocks were mixed. The SPDR S&P Regional Banking ETF slipped around 0.7%. Dime Community Bancshares also dropped about 0.7%, and Metropolitan Bank Holding lost roughly 1.2%. Hanover Bancorp bucked the trend, gaining roughly 0.9%.

NorthEast Community Bancorp runs NorthEast Community Bank, with locations and loan offices in New York and Massachusetts. Its stock is listed on Nasdaq, trading under NECB.

Stock Market Today

  • Rolls-Royce Shares Down 5.9% Over 3 Months: £1,000 Investment Now Worth £941
    May 27, 2026, 1:02 PM EDT. Rolls-Royce (LSE: RR.) shares fell 5.9% in three months, sliding from 1,386p to about 1,248p. A £1,000 investment three months ago would now be worth around £941, reflecting a £59 loss. The decline reflects geopolitical tensions impacting civil aviation, including US-Iran conflicts raising fuel supply concerns. Despite this, Rolls-Royce forecasts revenue growth from £22.7 billion this year to £27.54 billion by 2028, aided by business diversification beyond civil aviation. The stock trades at a moderate 18 P/E (price-to-earnings ratio), suggesting less valuation stretch compared to many growth stocks. Alternatives like AstraZeneca, valued at a 41.8% discount via discounted cash flow models but facing patent risks, and British American Tobacco also merit investor attention for growth and income potential.